Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple labeling and time-resolvable fluorophores.

E P Diamandis1

  • 1Department of Clinical Biochemistry, Toronto Western Hospital, Ontario, Canada.

Clinical Chemistry
|September 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electronic field effect detection of SARS-CoV-2 N-protein before the onset of symptoms.

Biosensors & bioelectronics·2022
Same author

A multi-cancer detection test: focus on the positive predictive value.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer.

British journal of cancer·2015
Same author

Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies.

Thrombosis and haemostasis·2013
Same author

Folate-receptor 1 (FOLR1) protein is elevated in the serum of ovarian cancer patients.

Clinical biochemistry·2013
Same author

CUB and zona pellucida-like domain-containing protein 1 (CUZD1): a novel serological biomarker for ovarian cancer.

Clinical biochemistry·2012

A novel time-resolved fluorescence immunoassay system utilizes a europium chelate label for enhanced sensitivity. This method, employing multiple labeling strategies, achieves improved detection limits for biomolecules like alpha-fetoprotein.

Area of Science:

  • Biochemistry
  • Analytical Chemistry
  • Immunotechnology

Background:

  • Time-resolved fluorescence immunoassays (TRFIAs) are crucial for sensitive biomolecule detection.
  • Traditional TRFIAs face limitations in achievable detection limits.
  • Development of novel labels and labeling strategies is essential for advancing immunoassay sensitivity.

Purpose of the Study:

  • To review a new time-resolved fluorescence immunoassay system.
  • To evaluate the utility of a specific europium chelate as a label.
  • To demonstrate improved detection limits through advanced labeling techniques.

Main Methods:

  • Utilized a europium chelate of 4,7-bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid as a label.
  • Employed multiple labeling strategies to enhance fluorescence.

Related Experiment Videos

  • Incorporated streptavidin tailing and Eu3+ activation for reagent stabilization.

    • Main Results:

    • The developed chelate, while not highly fluorescent alone, significantly improves detection limits when used in multiple labeling.
    • A stable, easy-to-use reagent was created using streptavidin-based macromolecular complexes.
    • The system detected approximately 300,000 molecules (0.5 amol) of alpha-fetoprotein in a model immunoassay.

    Conclusions:

    • The novel europium chelate system offers a stable and sensitive platform for immunoassays.
    • Multiple labeling strategies combined with streptavidin tailing and Eu3+ activation are effective for enhancing assay performance.
    • This approach is suitable for developing highly sensitive biotechnological assays, including those for biomarkers like alpha-fetoprotein.